Blog

Impurities

Chief Pharmacist

Impurities refer to unwanted substances or contaminants present in API or drug product. It can arise during manufacturing, handling, or ...

Innovator Drug

Chief Pharmacist

Innovator drug is a first time developed drug product through extensive research and clinical trials to demonstrate safety and efficacy. ...

Misbranded

Chief Pharmacist

A misbranded drug is a pharmaceutical product that has misleading information or false labeling or illegal advertising and violating regulatory ...

Over-the-Counter (OTC) Drug

Chief Pharmacist

OTC drugs are medications that can be purchased without a prescription for the treatment of minor ailments and conditions. As ...

Biodistribution (BD)

Chief Pharmacist

BD is the in vivo distribution, persistence, and clearance of a gene therapy (GT) product at the site of administration ...

Bioburden

Chief Pharmacist

The level and type (e.g. objectionable or not) of micro-organisms that can be present in raw materials, Active Pharmaceutical Ingredient ...

Biological Activity, Drugs and Matrix

Chief Pharmacist

Biological Activity The specific ability or capacity of the product to achieve a defined biological effect. Potency is the quantitative ...

Blinding in Clinical Trials

Chief Pharmacist

A procedure in which one or more parties to the trial are kept unaware of the treatment assignment(s). Single-blinding usually ...

Bridging Study

Chief Pharmacist

A bridging study is defined as a supplemental study performed in the new region to provide pharmacodynamic or clinical data ...

Business Case

Chief Pharmacist

The reason for making an investment (in whatever form), performing a process or using a tool. It often includes economic ...